Influencing Increased Transparency in Clinical Trials
The work focused on engaging with regulators for a general review of the legislation governing medications.
The goal was to influence stronger compliance around clinical trial registers, lodging and reporting.
Working with partners, the work sought to encourage the New Zealand Government to subscribe to the World Health Organisation joint statement on public disclosure of results from clinical trials.
- Meetings with the Health Research Council.
- Submission on the draft legislation.
Implementation of new policy & practice
- Meeting with senior officials at the Ministry of Health.
- The Ministry of Health has indicated its support for NZ signing up to the WHO joint statement on public disclosure of results from clinical trials. Whilst it cannot currently sign up (due to the rules on who can sign) it has recommended that the Health Research Council is the appropriate body, and has recommended to Council that this be progressed.
- There is potential for the change identified above to improve access by the public to information on current clinical trials.
- Connections with senior leadership at the Ministry of Health were established. This supported advocacy in a trusted environment.
- It was beneficial to highlighted the advantages to the Ministry of Health and the Health Research Council of engaging with NGO stakeholders and signing the WHO protocol.
- Skype and teleconferences was used to connect people without huge cost (health services are under stress in NZ).
- The submissions and advocacy resonated were designed to resonate with thinking that had been going on at the Ministry of Health and the Health Research Council.